nodes	percent_of_prediction	percent_of_DWPC	metapath
Cefepime—SLC22A5—Dactinomycin—testicular cancer	0.466	1	CbGbCtD
Cefepime—Infection—Dactinomycin—testicular cancer	0.000986	0.00185	CcSEcCtD
Cefepime—Vaginal infection—Doxorubicin—testicular cancer	0.000986	0.00185	CcSEcCtD
Cefepime—Aplastic anaemia—Doxorubicin—testicular cancer	0.00098	0.00184	CcSEcCtD
Cefepime—Sepsis—Epirubicin—testicular cancer	0.000979	0.00183	CcSEcCtD
Cefepime—Hepatic failure—Methotrexate—testicular cancer	0.000974	0.00182	CcSEcCtD
Cefepime—Pruritus—Chlorambucil—testicular cancer	0.000973	0.00182	CcSEcCtD
Cefepime—Thrombocytopenia—Dactinomycin—testicular cancer	0.000972	0.00182	CcSEcCtD
Cefepime—Convulsion—Ifosfamide—testicular cancer	0.000966	0.00181	CcSEcCtD
Cefepime—Erythema—Cisplatin—testicular cancer	0.000961	0.0018	CcSEcCtD
Cefepime—Erythema multiforme—Etoposide—testicular cancer	0.000956	0.00179	CcSEcCtD
Cefepime—Paraesthesia—Bleomycin—testicular cancer	0.000956	0.00179	CcSEcCtD
Cefepime—Coma—Doxorubicin—testicular cancer	0.000954	0.00179	CcSEcCtD
Cefepime—Phlebitis—Epirubicin—testicular cancer	0.000951	0.00178	CcSEcCtD
Cefepime—Dyspnoea—Bleomycin—testicular cancer	0.000949	0.00178	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Epirubicin—testicular cancer	0.000942	0.00176	CcSEcCtD
Cefepime—Diarrhoea—Chlorambucil—testicular cancer	0.000941	0.00176	CcSEcCtD
Cefepime—Hepatic function abnormal—Epirubicin—testicular cancer	0.000937	0.00176	CcSEcCtD
Cefepime—Hypersensitivity—Vinblastine—testicular cancer	0.000928	0.00174	CcSEcCtD
Cefepime—Confusional state—Ifosfamide—testicular cancer	0.000917	0.00172	CcSEcCtD
Cefepime—Hepatic failure—Epirubicin—testicular cancer	0.000912	0.00171	CcSEcCtD
Cefepime—Pain—Bleomycin—testicular cancer	0.00091	0.0017	CcSEcCtD
Cefepime—Anaphylactic shock—Ifosfamide—testicular cancer	0.000909	0.0017	CcSEcCtD
Cefepime—Chills—Etoposide—testicular cancer	0.000907	0.0017	CcSEcCtD
Cefepime—Sepsis—Doxorubicin—testicular cancer	0.000906	0.0017	CcSEcCtD
Cefepime—Infection—Ifosfamide—testicular cancer	0.000904	0.00169	CcSEcCtD
Cefepime—Thrombocytopenia—Ifosfamide—testicular cancer	0.00089	0.00167	CcSEcCtD
Cefepime—Anaemia—Cisplatin—testicular cancer	0.000888	0.00166	CcSEcCtD
Cefepime—Phlebitis—Doxorubicin—testicular cancer	0.00088	0.00165	CcSEcCtD
Cefepime—Feeling abnormal—Bleomycin—testicular cancer	0.000877	0.00164	CcSEcCtD
Cefepime—Vomiting—Chlorambucil—testicular cancer	0.000874	0.00164	CcSEcCtD
Cefepime—Blood alkaline phosphatase increased—Doxorubicin—testicular cancer	0.000871	0.00163	CcSEcCtD
Cefepime—Hepatic function abnormal—Doxorubicin—testicular cancer	0.000867	0.00162	CcSEcCtD
Cefepime—Diarrhoea—Vinblastine—testicular cancer	0.000862	0.00162	CcSEcCtD
Cefepime—Dysgeusia—Etoposide—testicular cancer	0.000862	0.00161	CcSEcCtD
Cefepime—Renal impairment—Epirubicin—testicular cancer	0.000861	0.00161	CcSEcCtD
Cefepime—Leukopenia—Cisplatin—testicular cancer	0.00086	0.00161	CcSEcCtD
Cefepime—Pain—Dactinomycin—testicular cancer	0.000849	0.00159	CcSEcCtD
Cefepime—Urticaria—Bleomycin—testicular cancer	0.000845	0.00158	CcSEcCtD
Cefepime—Hepatic failure—Doxorubicin—testicular cancer	0.000843	0.00158	CcSEcCtD
Cefepime—Body temperature increased—Bleomycin—testicular cancer	0.000841	0.00158	CcSEcCtD
Cefepime—Dizziness—Vinblastine—testicular cancer	0.000833	0.00156	CcSEcCtD
Cefepime—Convulsion—Cisplatin—testicular cancer	0.000832	0.00156	CcSEcCtD
Cefepime—Feeling abnormal—Dactinomycin—testicular cancer	0.000818	0.00153	CcSEcCtD
Cefepime—Nausea—Chlorambucil—testicular cancer	0.000817	0.00153	CcSEcCtD
Cefepime—Paraesthesia—Ifosfamide—testicular cancer	0.000817	0.00153	CcSEcCtD
Cefepime—Anaemia—Etoposide—testicular cancer	0.000813	0.00152	CcSEcCtD
Cefepime—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000812	0.00152	CcSEcCtD
Cefepime—Dyspnoea—Ifosfamide—testicular cancer	0.000811	0.00152	CcSEcCtD
Cefepime—Vomiting—Vinblastine—testicular cancer	0.000801	0.0015	CcSEcCtD
Cefepime—Renal impairment—Doxorubicin—testicular cancer	0.000796	0.00149	CcSEcCtD
Cefepime—Headache—Vinblastine—testicular cancer	0.000789	0.00148	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Methotrexate—testicular cancer	0.000788	0.00148	CcSEcCtD
Cefepime—Leukopenia—Etoposide—testicular cancer	0.000788	0.00148	CcSEcCtD
Cefepime—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000785	0.00147	CcSEcCtD
Cefepime—Body temperature increased—Dactinomycin—testicular cancer	0.000785	0.00147	CcSEcCtD
Cefepime—Abdominal pain—Dactinomycin—testicular cancer	0.000785	0.00147	CcSEcCtD
Cefepime—Anaphylactic shock—Cisplatin—testicular cancer	0.000784	0.00147	CcSEcCtD
Cefepime—Hypersensitivity—Bleomycin—testicular cancer	0.000784	0.00147	CcSEcCtD
Cefepime—Infection—Cisplatin—testicular cancer	0.000779	0.00146	CcSEcCtD
Cefepime—Constipation—Ifosfamide—testicular cancer	0.000778	0.00146	CcSEcCtD
Cefepime—Pain—Ifosfamide—testicular cancer	0.000778	0.00146	CcSEcCtD
Cefepime—Thrombocytopenia—Cisplatin—testicular cancer	0.000768	0.00144	CcSEcCtD
Cefepime—Convulsion—Etoposide—testicular cancer	0.000763	0.00143	CcSEcCtD
Cefepime—Pruritus—Bleomycin—testicular cancer	0.000753	0.00141	CcSEcCtD
Cefepime—Feeling abnormal—Ifosfamide—testicular cancer	0.000749	0.0014	CcSEcCtD
Cefepime—Eosinophilia—Methotrexate—testicular cancer	0.000749	0.0014	CcSEcCtD
Cefepime—Nausea—Vinblastine—testicular cancer	0.000748	0.0014	CcSEcCtD
Cefepime—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000744	0.00139	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Epirubicin—testicular cancer	0.000738	0.00138	CcSEcCtD
Cefepime—Hypersensitivity—Dactinomycin—testicular cancer	0.000731	0.00137	CcSEcCtD
Cefepime—Confusional state—Etoposide—testicular cancer	0.000724	0.00136	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Epirubicin—testicular cancer	0.000723	0.00135	CcSEcCtD
Cefepime—Urticaria—Ifosfamide—testicular cancer	0.000722	0.00135	CcSEcCtD
Cefepime—Body temperature increased—Ifosfamide—testicular cancer	0.000719	0.00135	CcSEcCtD
Cefepime—Abdominal pain—Ifosfamide—testicular cancer	0.000719	0.00135	CcSEcCtD
Cefepime—Pancytopenia—Methotrexate—testicular cancer	0.000719	0.00135	CcSEcCtD
Cefepime—Anaphylactic shock—Etoposide—testicular cancer	0.000718	0.00135	CcSEcCtD
Cefepime—Infection—Etoposide—testicular cancer	0.000714	0.00134	CcSEcCtD
Cefepime—Neutropenia—Methotrexate—testicular cancer	0.000707	0.00133	CcSEcCtD
Cefepime—Paraesthesia—Cisplatin—testicular cancer	0.000704	0.00132	CcSEcCtD
Cefepime—Thrombocytopenia—Etoposide—testicular cancer	0.000703	0.00132	CcSEcCtD
Cefepime—Eosinophilia—Epirubicin—testicular cancer	0.000701	0.00131	CcSEcCtD
Cefepime—Dyspnoea—Cisplatin—testicular cancer	0.000699	0.00131	CcSEcCtD
Cefepime—Toxic epidermal necrolysis—Doxorubicin—testicular cancer	0.000683	0.00128	CcSEcCtD
Cefepime—Bronchitis—Epirubicin—testicular cancer	0.000681	0.00128	CcSEcCtD
Cefepime—Diarrhoea—Dactinomycin—testicular cancer	0.000679	0.00127	CcSEcCtD
Cefepime—Pneumonia—Methotrexate—testicular cancer	0.000679	0.00127	CcSEcCtD
Cefepime—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000677	0.00127	CcSEcCtD
Cefepime—Vomiting—Bleomycin—testicular cancer	0.000677	0.00127	CcSEcCtD
Cefepime—Pancytopenia—Epirubicin—testicular cancer	0.000672	0.00126	CcSEcCtD
Cefepime—Rash—Bleomycin—testicular cancer	0.000671	0.00126	CcSEcCtD
Cefepime—Pain—Cisplatin—testicular cancer	0.00067	0.00126	CcSEcCtD
Cefepime—Dermatitis—Bleomycin—testicular cancer	0.00067	0.00126	CcSEcCtD
Cefepime—Hypersensitivity—Ifosfamide—testicular cancer	0.00067	0.00126	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000669	0.00125	CcSEcCtD
Cefepime—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.000669	0.00125	CcSEcCtD
Cefepime—Renal failure—Methotrexate—testicular cancer	0.000663	0.00124	CcSEcCtD
Cefepime—Neutropenia—Epirubicin—testicular cancer	0.000662	0.00124	CcSEcCtD
Cefepime—Eosinophilia—Doxorubicin—testicular cancer	0.000649	0.00122	CcSEcCtD
Cefepime—Feeling abnormal—Cisplatin—testicular cancer	0.000646	0.00121	CcSEcCtD
Cefepime—Paraesthesia—Etoposide—testicular cancer	0.000645	0.00121	CcSEcCtD
Cefepime—Pruritus—Ifosfamide—testicular cancer	0.000643	0.00121	CcSEcCtD
Cefepime—Dyspnoea—Etoposide—testicular cancer	0.00064	0.0012	CcSEcCtD
Cefepime—Pneumonia—Epirubicin—testicular cancer	0.000635	0.00119	CcSEcCtD
Cefepime—Nausea—Bleomycin—testicular cancer	0.000632	0.00118	CcSEcCtD
Cefepime—Vomiting—Dactinomycin—testicular cancer	0.000631	0.00118	CcSEcCtD
Cefepime—Bronchitis—Doxorubicin—testicular cancer	0.00063	0.00118	CcSEcCtD
Cefepime—Agranulocytosis—Methotrexate—testicular cancer	0.00063	0.00118	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000626	0.00117	CcSEcCtD
Cefepime—Rash—Dactinomycin—testicular cancer	0.000626	0.00117	CcSEcCtD
Cefepime—Diarrhoea—Ifosfamide—testicular cancer	0.000622	0.00117	CcSEcCtD
Cefepime—Pancytopenia—Doxorubicin—testicular cancer	0.000622	0.00117	CcSEcCtD
Cefepime—Renal failure—Epirubicin—testicular cancer	0.000621	0.00116	CcSEcCtD
Cefepime—Gastrointestinal disorder—Etoposide—testicular cancer	0.00062	0.00116	CcSEcCtD
Cefepime—Body temperature increased—Cisplatin—testicular cancer	0.00062	0.00116	CcSEcCtD
Cefepime—Constipation—Etoposide—testicular cancer	0.000614	0.00115	CcSEcCtD
Cefepime—Pain—Etoposide—testicular cancer	0.000614	0.00115	CcSEcCtD
Cefepime—Urinary tract infection—Epirubicin—testicular cancer	0.000614	0.00115	CcSEcCtD
Cefepime—Neutropenia—Doxorubicin—testicular cancer	0.000613	0.00115	CcSEcCtD
Cefepime—Haemoglobin—Methotrexate—testicular cancer	0.000609	0.00114	CcSEcCtD
Cefepime—Haemorrhage—Methotrexate—testicular cancer	0.000606	0.00113	CcSEcCtD
Cefepime—Dizziness—Ifosfamide—testicular cancer	0.000601	0.00113	CcSEcCtD
Cefepime—Feeling abnormal—Etoposide—testicular cancer	0.000592	0.00111	CcSEcCtD
Cefepime—Nausea—Dactinomycin—testicular cancer	0.00059	0.0011	CcSEcCtD
Cefepime—Agranulocytosis—Epirubicin—testicular cancer	0.000589	0.0011	CcSEcCtD
Cefepime—Pneumonia—Doxorubicin—testicular cancer	0.000588	0.0011	CcSEcCtD
Cefepime—Gastrointestinal pain—Etoposide—testicular cancer	0.000587	0.0011	CcSEcCtD
Cefepime—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.000579	0.00108	CcSEcCtD
Cefepime—Vomiting—Ifosfamide—testicular cancer	0.000578	0.00108	CcSEcCtD
Cefepime—Hypersensitivity—Cisplatin—testicular cancer	0.000578	0.00108	CcSEcCtD
Cefepime—Renal failure—Doxorubicin—testicular cancer	0.000574	0.00108	CcSEcCtD
Cefepime—Rash—Ifosfamide—testicular cancer	0.000573	0.00107	CcSEcCtD
Cefepime—Dermatitis—Ifosfamide—testicular cancer	0.000573	0.00107	CcSEcCtD
Cefepime—Erythema multiforme—Methotrexate—testicular cancer	0.000573	0.00107	CcSEcCtD
Cefepime—Urticaria—Etoposide—testicular cancer	0.000571	0.00107	CcSEcCtD
Cefepime—Haemoglobin—Epirubicin—testicular cancer	0.00057	0.00107	CcSEcCtD
Cefepime—Body temperature increased—Etoposide—testicular cancer	0.000568	0.00106	CcSEcCtD
Cefepime—Abdominal pain—Etoposide—testicular cancer	0.000568	0.00106	CcSEcCtD
Cefepime—Urinary tract infection—Doxorubicin—testicular cancer	0.000568	0.00106	CcSEcCtD
Cefepime—Haemorrhage—Epirubicin—testicular cancer	0.000567	0.00106	CcSEcCtD
Cefepime—Agranulocytosis—Doxorubicin—testicular cancer	0.000545	0.00102	CcSEcCtD
Cefepime—Chills—Methotrexate—testicular cancer	0.000543	0.00102	CcSEcCtD
Cefepime—Nausea—Ifosfamide—testicular cancer	0.00054	0.00101	CcSEcCtD
Cefepime—Diarrhoea—Cisplatin—testicular cancer	0.000536	0.00101	CcSEcCtD
Cefepime—Erythema multiforme—Epirubicin—testicular cancer	0.000536	0.001	CcSEcCtD
Cefepime—Hypersensitivity—Etoposide—testicular cancer	0.000529	0.000991	CcSEcCtD
Cefepime—Erythema—Methotrexate—testicular cancer	0.000527	0.000988	CcSEcCtD
Cefepime—Haemoglobin—Doxorubicin—testicular cancer	0.000527	0.000987	CcSEcCtD
Cefepime—Haemorrhage—Doxorubicin—testicular cancer	0.000524	0.000982	CcSEcCtD
Cefepime—Dysgeusia—Methotrexate—testicular cancer	0.000516	0.000967	CcSEcCtD
Cefepime—Chills—Epirubicin—testicular cancer	0.000509	0.000953	CcSEcCtD
Cefepime—Pruritus—Etoposide—testicular cancer	0.000508	0.000952	CcSEcCtD
Cefepime—Vomiting—Cisplatin—testicular cancer	0.000499	0.000934	CcSEcCtD
Cefepime—Erythema multiforme—Doxorubicin—testicular cancer	0.000496	0.000929	CcSEcCtD
Cefepime—Rash—Cisplatin—testicular cancer	0.000494	0.000926	CcSEcCtD
Cefepime—Dermatitis—Cisplatin—testicular cancer	0.000494	0.000925	CcSEcCtD
Cefepime—Erythema—Epirubicin—testicular cancer	0.000493	0.000924	CcSEcCtD
Cefepime—Diarrhoea—Etoposide—testicular cancer	0.000491	0.000921	CcSEcCtD
Cefepime—Anaemia—Methotrexate—testicular cancer	0.000487	0.000913	CcSEcCtD
Cefepime—Dysgeusia—Epirubicin—testicular cancer	0.000483	0.000905	CcSEcCtD
Cefepime—Dizziness—Etoposide—testicular cancer	0.000475	0.00089	CcSEcCtD
Cefepime—Leukopenia—Methotrexate—testicular cancer	0.000472	0.000884	CcSEcCtD
Cefepime—Chills—Doxorubicin—testicular cancer	0.000471	0.000881	CcSEcCtD
Cefepime—Nausea—Cisplatin—testicular cancer	0.000466	0.000872	CcSEcCtD
Cefepime—Convulsion—Methotrexate—testicular cancer	0.000457	0.000856	CcSEcCtD
Cefepime—Vomiting—Etoposide—testicular cancer	0.000457	0.000856	CcSEcCtD
Cefepime—Erythema—Doxorubicin—testicular cancer	0.000456	0.000855	CcSEcCtD
Cefepime—Anaemia—Epirubicin—testicular cancer	0.000456	0.000854	CcSEcCtD
Cefepime—Agitation—Epirubicin—testicular cancer	0.000453	0.000849	CcSEcCtD
Cefepime—Rash—Etoposide—testicular cancer	0.000453	0.000848	CcSEcCtD
Cefepime—Dermatitis—Etoposide—testicular cancer	0.000452	0.000848	CcSEcCtD
Cefepime—Headache—Etoposide—testicular cancer	0.00045	0.000843	CcSEcCtD
Cefepime—Dysgeusia—Doxorubicin—testicular cancer	0.000447	0.000837	CcSEcCtD
Cefepime—Leukopenia—Epirubicin—testicular cancer	0.000442	0.000827	CcSEcCtD
Cefepime—Confusional state—Methotrexate—testicular cancer	0.000434	0.000813	CcSEcCtD
Cefepime—Anaphylactic shock—Methotrexate—testicular cancer	0.00043	0.000806	CcSEcCtD
Cefepime—Convulsion—Epirubicin—testicular cancer	0.000427	0.000801	CcSEcCtD
Cefepime—Infection—Methotrexate—testicular cancer	0.000427	0.000801	CcSEcCtD
Cefepime—Nausea—Etoposide—testicular cancer	0.000427	0.000799	CcSEcCtD
Cefepime—Anaemia—Doxorubicin—testicular cancer	0.000422	0.00079	CcSEcCtD
Cefepime—Thrombocytopenia—Methotrexate—testicular cancer	0.000421	0.000789	CcSEcCtD
Cefepime—Agitation—Doxorubicin—testicular cancer	0.000419	0.000786	CcSEcCtD
Cefepime—Leukopenia—Doxorubicin—testicular cancer	0.000409	0.000765	CcSEcCtD
Cefepime—Confusional state—Epirubicin—testicular cancer	0.000406	0.000761	CcSEcCtD
Cefepime—Anaphylactic shock—Epirubicin—testicular cancer	0.000403	0.000754	CcSEcCtD
Cefepime—Infection—Epirubicin—testicular cancer	0.0004	0.000749	CcSEcCtD
Cefepime—Shock—Epirubicin—testicular cancer	0.000396	0.000742	CcSEcCtD
Cefepime—Convulsion—Doxorubicin—testicular cancer	0.000396	0.000741	CcSEcCtD
Cefepime—Thrombocytopenia—Epirubicin—testicular cancer	0.000394	0.000739	CcSEcCtD
Cefepime—Paraesthesia—Methotrexate—testicular cancer	0.000386	0.000724	CcSEcCtD
Cefepime—Dyspnoea—Methotrexate—testicular cancer	0.000384	0.000719	CcSEcCtD
Cefepime—Confusional state—Doxorubicin—testicular cancer	0.000376	0.000704	CcSEcCtD
Cefepime—Anaphylactic shock—Doxorubicin—testicular cancer	0.000373	0.000698	CcSEcCtD
Cefepime—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000371	0.000696	CcSEcCtD
Cefepime—Infection—Doxorubicin—testicular cancer	0.00037	0.000693	CcSEcCtD
Cefepime—Pain—Methotrexate—testicular cancer	0.000368	0.000689	CcSEcCtD
Cefepime—Shock—Doxorubicin—testicular cancer	0.000367	0.000687	CcSEcCtD
Cefepime—Thrombocytopenia—Doxorubicin—testicular cancer	0.000365	0.000683	CcSEcCtD
Cefepime—Paraesthesia—Epirubicin—testicular cancer	0.000362	0.000677	CcSEcCtD
Cefepime—Dyspnoea—Epirubicin—testicular cancer	0.000359	0.000672	CcSEcCtD
Cefepime—Feeling abnormal—Methotrexate—testicular cancer	0.000355	0.000664	CcSEcCtD
Cefepime—Gastrointestinal pain—Methotrexate—testicular cancer	0.000352	0.000659	CcSEcCtD
Cefepime—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000348	0.000651	CcSEcCtD
Cefepime—Constipation—Epirubicin—testicular cancer	0.000344	0.000645	CcSEcCtD
Cefepime—Pain—Epirubicin—testicular cancer	0.000344	0.000645	CcSEcCtD
Cefepime—Urticaria—Methotrexate—testicular cancer	0.000342	0.00064	CcSEcCtD
Cefepime—Abdominal pain—Methotrexate—testicular cancer	0.00034	0.000637	CcSEcCtD
Cefepime—Body temperature increased—Methotrexate—testicular cancer	0.00034	0.000637	CcSEcCtD
Cefepime—Paraesthesia—Doxorubicin—testicular cancer	0.000335	0.000627	CcSEcCtD
Cefepime—Dyspnoea—Doxorubicin—testicular cancer	0.000332	0.000622	CcSEcCtD
Cefepime—Feeling abnormal—Epirubicin—testicular cancer	0.000332	0.000622	CcSEcCtD
Cefepime—Gastrointestinal pain—Epirubicin—testicular cancer	0.000329	0.000617	CcSEcCtD
Cefepime—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000322	0.000603	CcSEcCtD
Cefepime—Urticaria—Epirubicin—testicular cancer	0.00032	0.000599	CcSEcCtD
Cefepime—Pain—Doxorubicin—testicular cancer	0.000319	0.000597	CcSEcCtD
Cefepime—Constipation—Doxorubicin—testicular cancer	0.000319	0.000597	CcSEcCtD
Cefepime—Body temperature increased—Epirubicin—testicular cancer	0.000318	0.000596	CcSEcCtD
Cefepime—Abdominal pain—Epirubicin—testicular cancer	0.000318	0.000596	CcSEcCtD
Cefepime—Hypersensitivity—Methotrexate—testicular cancer	0.000317	0.000594	CcSEcCtD
Cefepime—Feeling abnormal—Doxorubicin—testicular cancer	0.000307	0.000575	CcSEcCtD
Cefepime—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000305	0.000571	CcSEcCtD
Cefepime—Pruritus—Methotrexate—testicular cancer	0.000304	0.00057	CcSEcCtD
Cefepime—Hypersensitivity—Epirubicin—testicular cancer	0.000297	0.000556	CcSEcCtD
Cefepime—Urticaria—Doxorubicin—testicular cancer	0.000296	0.000554	CcSEcCtD
Cefepime—Abdominal pain—Doxorubicin—testicular cancer	0.000295	0.000552	CcSEcCtD
Cefepime—Body temperature increased—Doxorubicin—testicular cancer	0.000295	0.000552	CcSEcCtD
Cefepime—Diarrhoea—Methotrexate—testicular cancer	0.000294	0.000551	CcSEcCtD
Cefepime—Pruritus—Epirubicin—testicular cancer	0.000285	0.000534	CcSEcCtD
Cefepime—Dizziness—Methotrexate—testicular cancer	0.000285	0.000533	CcSEcCtD
Cefepime—Diarrhoea—Epirubicin—testicular cancer	0.000275	0.000516	CcSEcCtD
Cefepime—Hypersensitivity—Doxorubicin—testicular cancer	0.000274	0.000514	CcSEcCtD
Cefepime—Vomiting—Methotrexate—testicular cancer	0.000274	0.000512	CcSEcCtD
Cefepime—Rash—Methotrexate—testicular cancer	0.000271	0.000508	CcSEcCtD
Cefepime—Dermatitis—Methotrexate—testicular cancer	0.000271	0.000508	CcSEcCtD
Cefepime—Headache—Methotrexate—testicular cancer	0.00027	0.000505	CcSEcCtD
Cefepime—Dizziness—Epirubicin—testicular cancer	0.000266	0.000499	CcSEcCtD
Cefepime—Pruritus—Doxorubicin—testicular cancer	0.000264	0.000494	CcSEcCtD
Cefepime—Vomiting—Epirubicin—testicular cancer	0.000256	0.00048	CcSEcCtD
Cefepime—Nausea—Methotrexate—testicular cancer	0.000256	0.000479	CcSEcCtD
Cefepime—Diarrhoea—Doxorubicin—testicular cancer	0.000255	0.000478	CcSEcCtD
Cefepime—Rash—Epirubicin—testicular cancer	0.000254	0.000476	CcSEcCtD
Cefepime—Dermatitis—Epirubicin—testicular cancer	0.000254	0.000475	CcSEcCtD
Cefepime—Headache—Epirubicin—testicular cancer	0.000252	0.000473	CcSEcCtD
Cefepime—Dizziness—Doxorubicin—testicular cancer	0.000246	0.000462	CcSEcCtD
Cefepime—Nausea—Epirubicin—testicular cancer	0.000239	0.000448	CcSEcCtD
Cefepime—Vomiting—Doxorubicin—testicular cancer	0.000237	0.000444	CcSEcCtD
Cefepime—Rash—Doxorubicin—testicular cancer	0.000235	0.00044	CcSEcCtD
Cefepime—Dermatitis—Doxorubicin—testicular cancer	0.000235	0.00044	CcSEcCtD
Cefepime—Headache—Doxorubicin—testicular cancer	0.000233	0.000437	CcSEcCtD
Cefepime—Nausea—Doxorubicin—testicular cancer	0.000221	0.000415	CcSEcCtD
